Vincristine, bleomycin, mitomycin C, cisplatin combination chemotherapy as additive treatment to radiotherapy in poor risk patients with squamous cell carcinoma of the uterine cervix

Prog Clin Biol Res. 1985:201:225-37.

Authors

J B Vermorken, M E vd Burg, A J Subandono, C Mangioni, C F De Oliveira, P Zola, A T van Oosterom, S Pecorelli, A C van Lindert

PMID: 2419917

No abstract available

MeSH terms

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Bleomycin / adverse effects
Bleomycin / therapeutic use
Carcinoma, Squamous Cell / mortality
Carcinoma, Squamous Cell / radiotherapy
Carcinoma, Squamous Cell / therapy*
Cisplatin / adverse effects
Cisplatin / therapeutic use
Combined Modality Therapy
Female
Humans
Middle Aged
Mitomycin
Mitomycins / adverse effects
Mitomycins / therapeutic use
Radiotherapy / adverse effects
Risk
Uterine Cervical Neoplasms / mortality
Uterine Cervical Neoplasms / radiotherapy
Uterine Cervical Neoplasms / therapy*
Vincristine / adverse effects
Vincristine / therapeutic use

Substances

Mitomycins
Bleomycin
Mitomycin
Vincristine
Cisplatin

Supplementary concepts

BOMP protocol